Location History:
- Beijing, CN (2018)
- Shanghai, CN (2020 - 2023)
Company Filing History:
2 out of 164,197 
2 out of 118 
1 out of 1 Years Active: 2018-2025
Title: Innovations and Contributions of Inventor Ao Qiong Li
Introduction
Ao Qiong Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. With a total of 8 patents to his name, his work has the potential to impact the treatment of various diseases, including cancers.
Latest Patents
Among his latest patents, one notable invention is related to cyclic molecules as Bruton's tyrosine kinase inhibitors. This invention focuses on a novel molecule with protein tyrosine kinase inhibitory activity, detailing the synthesis and usage of the compound. Another significant patent involves heterocyclic compounds as kinase inhibitors, which includes therapeutic uses of these compounds. This patent also describes a pharmaceutical composition that comprises a compound of Formula (I) and a pharmaceutically acceptable carrier.
Career Highlights
Throughout his career, Ao Qiong Li has worked with reputable organizations, including IBM and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His experience in these companies has contributed to his expertise in the field of drug development and innovation.
Collaborations
He has collaborated with notable coworkers such as Yuanshan Yao and Yicheng Feng, further enhancing his research and development efforts.
Conclusion
Ao Qiong Li's innovative work in the field of kinase inhibitors showcases his dedication to advancing pharmaceutical science. His contributions have the potential to lead to significant advancements in the treatment of various diseases.